Company intelligence / Profile preview

Wyeth

Philadelphia, Pennsylvania, United Stateswyeth.nyc ↗

Ownership: Private
Employees: ~52289
Development stage: Commercial

Overview

Wyeth was a major pharmaceutical company with products across multiple therapeutic areas including vaccines, prescription medications, and consumer health products

Therapeutic areas: PsychiatryCardiovascularImmunologyWomen's HealthNeurologyInfectious Diseases
Modalities: Small moleculesbiologicsvaccines
Industry: Pharma

Drug pipeline

2 assets

pneumococcal 7-valent conjugate vaccine (Wyeth)

Approved

1 more asset in the full pipeline.

Request access →

Partnerships

World Health Organization (for smallpox eradication)

Beyond the preview

Go deeper on Wyeth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wyeth.

Explore the full profile